162 related articles for article (PubMed ID: 37768074)
1. A multidomain intervention against cognitive decline in an at-risk-population in Germany: Results from the cluster-randomized AgeWell.de trial.
Zülke AE; Pabst A; Luppa M; Roehr S; Seidling H; Oey A; Cardona MI; Blotenberg I; Bauer A; Weise S; Zöllinger I; Sanftenberg L; Brettschneider C; Döhring J; Lunden L; Czock D; Haefeli WE; Wiese B; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Thyrian JR; Riedel-Heller SG
Alzheimers Dement; 2024 Jan; 20(1):615-628. PubMed ID: 37768074
[TBL] [Abstract][Full Text] [Related]
2. AgeWell.de - study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients.
Zülke A; Luck T; Pabst A; Hoffmann W; Thyrian JR; Gensichen J; Kaduszkiewicz H; König HH; Haefeli WE; Czock D; Wiese B; Frese T; Röhr S; Riedel-Heller SG
BMC Geriatr; 2019 Aug; 19(1):203. PubMed ID: 31370792
[TBL] [Abstract][Full Text] [Related]
3. Recruitment and Baseline Characteristics of Participants in the AgeWell.de Study-A Pragmatic Cluster-Randomized Controlled Lifestyle Trial against Cognitive Decline.
Röhr S; Zülke A; Luppa M; Brettschneider C; Weißenborn M; Kühne F; Zöllinger I; Samos FZ; Bauer A; Döhring J; Krebs-Hein K; Oey A; Czock D; Frese T; Gensichen J; Haefeli WE; Hoffmann W; Kaduszkiewicz H; König HH; Thyrian JR; Wiese B; Riedel-Heller SG
Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33430189
[TBL] [Abstract][Full Text] [Related]
4. GOIZ ZAINDU study: a FINGER-like multidomain lifestyle intervention feasibility randomized trial to prevent dementia in Southern Europe.
Tainta M; Ecay-Torres M; de Arriba M; Barandiaran M; Otaegui-Arrazola A; Iriondo A; Garcia-Sebastian M; Estanga A; Saldias J; Clerigue M; Gabilondo A; Ros N; Mugica J; Barandiaran A; Mangialasche F; Kivipelto M; Arrospide A; Mar J; Martinez-Lage P;
Alzheimers Res Ther; 2024 Feb; 16(1):44. PubMed ID: 38413990
[TBL] [Abstract][Full Text] [Related]
5. Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial.
Rosenberg A; Ngandu T; Rusanen M; Antikainen R; Bäckman L; Havulinna S; Hänninen T; Laatikainen T; Lehtisalo J; Levälahti E; Lindström J; Paajanen T; Peltonen M; Soininen H; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Solomon A; Kivipelto M
Alzheimers Dement; 2018 Mar; 14(3):263-270. PubMed ID: 29055814
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. A multidomain lifestyle intervention to maintain optimal cognitive functioning in Dutch older adults-study design and baseline characteristics of the FINGER-NL randomized controlled trial.
Deckers K; Zwan MD; Soons LM; Waterink L; Beers S; van Houdt S; Stiensma B; Kwant JZ; Wimmers SCPM; Heutz RAM; Claassen JAHR; Oosterman JM; de Heus RAA; van de Rest O; Vermeiren Y; Voshaar RCO; Smidt N; Broersen LM; Sikkes SAM; Aarts E; ; ; Köhler S; van der Flier WM
Alzheimers Res Ther; 2024 Jun; 16(1):126. PubMed ID: 38872204
[TBL] [Abstract][Full Text] [Related]
8. A Mediterranean Diet and Walking Intervention to Reduce Cognitive Decline and Dementia Risk in Independently Living Older Australians: The MedWalk Randomized Controlled Trial Experimental Protocol, Including COVID-19 Related Modifications and Baseline Characteristics.
Pipingas A; Murphy KJ; Davis CR; Itsiopoulos C; Kingsley M; Scholey A; Macpherson H; Segal L; Breckon J; Minihane AM; Meyer D; Ogden E; Dyer KA; Eversteyn E; Hardman RJ; Poorun K; Justice K; Hana M; Buckley JD; White D; Davison K; Clark JS; Bracci EL; Kennedy G;
J Alzheimers Dis; 2023; 96(1):409-427. PubMed ID: 37781806
[TBL] [Abstract][Full Text] [Related]
9. The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER): Study Design and Protocol.
Xu X; Chew KA; Wong ZX; Phua AKS; Chong EJY; Teo CKL; Sathe N; Chooi YC; Chia WPF; Henry CJ; Chew E; Wang M; Maier AB; Kandiah N; Chen CL
J Prev Alzheimers Dis; 2022; 9(1):40-48. PubMed ID: 35098972
[TBL] [Abstract][Full Text] [Related]
10. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress.
Kivipelto M; Solomon A; Ahtiluoto S; Ngandu T; Lehtisalo J; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lindström J; Mangialasche F; Nissinen A; Paajanen T; Pajala S; Peltonen M; Rauramaa R; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H
Alzheimers Dement; 2013 Nov; 9(6):657-65. PubMed ID: 23332672
[TBL] [Abstract][Full Text] [Related]
11. Multi-domain interventions for the prevention of dementia and cognitive decline.
Hafdi M; Hoevenaar-Blom MP; Richard E
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013572. PubMed ID: 34748207
[TBL] [Abstract][Full Text] [Related]
12. Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment.
McMaster M; Kim S; Clare L; Torres SJ; D'Este C; Anstey KJ
Clin Interv Aging; 2018; 13():2397-2406. PubMed ID: 30538436
[TBL] [Abstract][Full Text] [Related]
13. Who Benefited the Most? Effectiveness of a Lifestyle Intervention Against Cognitive Decline in Older Women and Men - Secondary Analysis of the AgeWell.de-trial.
Wittmann FG; Pabst A; Zülke A; Luppa M; Blotenberg I; Cardona MI; Bauer A; Fuchs S; Zöllinger I; Sanftenberg L; Brettschneider C; Döhring J; Lunden L; Czock D; Wiese B; Thyrian JR; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Riedel-Heller SG
J Prev Alzheimers Dis; 2024; 11(2):348-355. PubMed ID: 38374741
[TBL] [Abstract][Full Text] [Related]
14. Effect of Personalized Risk-Reduction Strategies on Cognition and Dementia Risk Profile Among Older Adults: The SMARRT Randomized Clinical Trial.
Yaffe K; Vittinghoff E; Dublin S; Peltz CB; Fleckenstein LE; Rosenberg DE; Barnes DE; Balderson BH; Larson EB
JAMA Intern Med; 2024 Jan; 184(1):54-62. PubMed ID: 38010725
[TBL] [Abstract][Full Text] [Related]
15. Cognitive Benefit of a Multidomain Intervention for Older Adults at Risk of Cognitive Decline: A Cluster-Randomized Controlled Trial.
Liu X; Ma Z; Zhu X; Zheng Z; Li J; Fu J; Shao Q; Han X; Wang X; Wang Z; Yin Z; Qiu C; Li J
Am J Geriatr Psychiatry; 2023 Mar; 31(3):197-209. PubMed ID: 36414488
[TBL] [Abstract][Full Text] [Related]
16. Multidomain interventions based on a life-course model to prevent dementia in at-risk Chinese older adults: A randomized controlled trial.
Meng X; Su J; Gao T; Ma D; Zhao Y; Fang S; Zhi S; Li H; Sun J
Int J Nurs Stud; 2024 Apr; 152():104701. PubMed ID: 38330865
[TBL] [Abstract][Full Text] [Related]
17. Adherence to a lifestyle intervention - just a question of self-efficacy? Analysis of the AgeWell.de-intervention against cognitive decline.
Wittmann FG; Pabst A; Zülke A; Luppa M; Oey A; Boekholt M; Weise S; Fankhänel T; Kosilek RP; Brettschneider C; Döhring J; Lunden L; Wiese B; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Thyrian JR; Riedel-Heller SG
Alzheimers Res Ther; 2024 Jun; 16(1):133. PubMed ID: 38909256
[TBL] [Abstract][Full Text] [Related]
18. Effect of a Multidomain Lifestyle Intervention on Estimated Dementia Risk.
Solomon A; Handels R; Wimo A; Antikainen R; Laatikainen T; Levälahti E; Peltonen M; Soininen H; Strandberg T; Tuomilehto J; Kivipelto M; Ngandu T
J Alzheimers Dis; 2021; 82(4):1461-1466. PubMed ID: 34151805
[TBL] [Abstract][Full Text] [Related]
19. The Japan-Multimodal Intervention Trial for Prevention of Dementia (J-MINT): The Study Protocol for an 18-Month, Multicenter, Randomized, Controlled Trial.
Sugimoto T; Sakurai T; Akatsu H; Doi T; Fujiwara Y; Hirakawa A; Kinoshita F; Kuzuya M; Lee S; Matsuo K; Michikawa M; Ogawa S; Otsuka R; Sato K; Shimada H; Suzuki H; Suzuki H; Takechi H; Takeda S; Umegaki H; Wakayama S; Arai H
J Prev Alzheimers Dis; 2021; 8(4):465-476. PubMed ID: 34585222
[TBL] [Abstract][Full Text] [Related]
20. Roles of Baseline Intrinsic Capacity and its Subdomains on the Overall Efficacy of Multidomain Intervention in Promoting Healthy Aging among Community-Dwelling Older Adults: Analysis from a Nationwide Cluster-Randomized Controlled Trial.
Liang CK; Lee WJ; Chou MY; Hwang AC; Lin CS; Peng LN; Hsiao FY; Loh CH; Chen LK
J Prev Alzheimers Dis; 2024; 11(2):356-365. PubMed ID: 38374742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
